Journal article
Lung Cancer–Related Clinical and Economic Impacts of Achieving a 5% Smoking Prevalence Rate by 2035 in Canada
Abstract
Background: Smoking is responsible for nearly 85% of lung cancer cases and 30% of all cancer-related deaths. Canada has set an ambitious target to reduce tobacco use to 5% by 2035 in alignment with a world-wide tobacco endgame initiative. Aim: We project the impact of achieving a national 5% smoking prevalence rate by 2035 on population-level lung cancer outcomes and costs. Methods: OncoSim-Lung (version 2.5), led by the Canadian Partnership …
Authors
Gauvreau C; Fitzgerald N; Hussain S; Memon S; Flanagan W; Miller A; Goffin J; Evans W
Journal
Journal of Global Oncology, Vol. 4, No. Supplement 2, pp. 28s–28s
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
October 1, 2018
DOI
10.1200/jgo.18.27500
ISSN
2378-9506